Medine ALPDEMİR, Mehmet Fatih ALPDEMİR

The prevalence of illegal substance use of the Balikesir region in Turkey; A laboratory data mining study

The purpose of this study is showed the prevalence of illegal substance use in our region according to the drug abuse screening test results of our laboratory. In this study, the data of urine specimens were retrospectively analyzed from the biochemistry laboratory information system of Balikesir State Hospital between July 2016 and November 2018 in Turkey. After the samples are taken, the properties of urine (quantity, temperature, appearance) and composition of urine (creatinine, pH, density, nitrite, oxidant) are analyzed for convenience. In our laboratory; drug abuse screening is performed for amphetamine, benzodiazepine, opiate, cocaine, cannabinoid, buprenorphine, barbiturate, ecstasy, and synthetic cannabinoid -1, 2, 3 tests. During this period, A total of 3071 samples of 1093 patients were accepted for urine analysis (M: 97.4%, F: 2.6%). 95.6% of the cases were of probation, 1.2% of the clinics (emergency and intensive care) and 3.2% of came for the job application. The positivity rate was 19.3% according to the number of patients, was 12.9% according to the total number of samples analyzed. The most commonly used substance was cannabinoid. This was followed by ecstasy, amphetamine, synthetic cannabinoid-3, and benzodiazepine. In conclusion, analysis of the substance use profile based on the laboratory data, information on substance use prevalence and profile is thought to be useful for preventive studies.

PDF

___

1. Arslan DT, Akbulut Y. Analysis of policies toward drugs by Turkey’s Ministry of Health. Addicta. 2014;4:151-83.

2. Türkiye Sağlık Bakanlığı. İdrar numunelerinde yasadışı ve kötüye kullanılan ilaç ve madde analizi yapan tıbbi laboratuarlar ile madde bağımlılığı teşhis ve tedavi merkezlerindeki laboratuvarların işleyiş esasları 2016 [Online]. Website: https://dosyamerkez.saglik.gov.tr/Eklenti/5907,idrar-numunelerinde-yasadisi-vek22255513pdf.pdf accessed date 07.06.2018

3. Küme T, Karakükcü Ç, Pinar A, et al. The scope, quality and safety requirements of drug abuse testing. Türk Psikiyatri Dergisi 2017;28:198-207.

4. Sahin ON, Serdar M, Serteser M, et al. Vitamin D levels and parathyroid hormone variations of children living in a subtropical climate: a data mining study. Ital J Pediatr. 2018;44:40.

5. Martin-Sanchez FJ, Aguiar-Pulido V, Lopez-Campos GH, et al. Secondary use and analysis of big data collected for patient care. Yearb Med Inform. 2017;26:28-37.

6. Turkey monitoring centre for drugs and drug addiction (TUBİM). Turkey drug report 2018. http://www.narkotik.pol.tr/TUBIM/Documents/2018%20TURKIYE%20UYUSTURUCU%20RAPORU.pdf accessed date 13.01.2019

7. Turkey monitoring center for drugs and drug addiction (TUBİM). Turkey drug report 2014. http://www.narkotik.pol.tr/TUBIM/Documents/TURKIYE%20UYUSTURUCU%20RAPORU%202014.pdf accessed date 13.01.2019

8. United nations office on drugs and crime (UNODC). The world drug report 2018. https://www.unodc.org/wdr2018/index.html accessed date 13.01.2019

9. Kulaksızoğlu B, Kulaksızoğlu S, Ellidağ HY, et al. Investigation of narcotic substance use among individuals who were under probation in the city of Antalya. The Bulletin of Legal Medicine 2015;20:21-6.

10. Karakükcü Ç, Çiraci MZ, Koçer D, et al. Regional drug abuse prevalence depending on laboratory-based urine illicit drug screening results. Anatol J Psychiatry 2018;19:169-76.

11. European monitoring center for drugs and drug addiction (EMCDDA). european drug report 2018. http://www.emcdda.europa.eu/edr2018_en. European Drug Report 2018: Trends and Developments accessed dete 07.01.2018.

12. Zolala F, Mahdavian M, Haghdoost AA, et al. Pathways to Addiction: A gender-based study on drug use in a triangular clinic and drop-in center, Kerman, Iran. Int J High Risk Behav Addict 2016;5:e22320.

13. Lal R, Deb KS, Kedia S. Substance use in women: Current status and future directions. Indian j Psychiatry 2015;57(Suppl 2):S275-85.

14. McHugh RK, Votaw VR, Sugarman DE, et al. Sex and gender differences in substance use disorders. Clin Psychol Rev 2018;66:12-23.

15. United kingdom of great britain and northern Ireland, office for national statistics, “Drug misuse: findings from the 2016/17 crime survey for England and Wales”, Statistical Bulletin 11/17. London, July 2017.